<drug type="small molecule" created="2015-11-30" updated="2017-03-10">
  <drugbank-id primary="true">DB09502</drugbank-id>
  <name>Fludeoxyglucose F-18</name>
  <description>Fludeoxyglucose F 18 Injection is a positron emitting radiopharmaceutical containing no-carrier added radioactive 2-deoxy-2-[18F]fluoro-D-g1ucose, which is used for diagnostic purposes in conjunction with Positron Emission Tomography (PET). It is administered by intravenous injection.</description>
  <cas-number/>
  <unii/>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <pubmed-id>26159590</pubmed-id>
        <citation>Tragardh M, Moller N, Sorensen M: Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects. J Nucl Med. 2015 Sep;56(9):1366-71. doi: 10.2967/jnumed.115.154211. Epub 2015 Jul 9.</citation>
      </article>
      <article>
        <pubmed-id>15883258</pubmed-id>
        <citation>Mega MS, Dinov ID, Porter V, Chow G, Reback E, Davoodi P, O'Connor SM, Carter MF, Amezcua H, Cummings JL: Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study. Arch Neurol. 2005 May;62(5):721-8.</citation>
      </article>
      <article>
        <pubmed-id>7848128</pubmed-id>
        <citation>Perani D, Bressi S, Testa D, Grassi F, Cortelli P, Gentrini S, Savoiardo M, Caraceni T, Fazio F: Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study. Arch Neurol. 1995 Feb;52(2):179-85.</citation>
      </article>
    </articles>
    <textbooks/>
    <links>
      <link>
        <title>FDA Label</title>
        <url>https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021870lbl.pdf</url>
      </link>
      <link>
        <title>Wikipedia</title>
        <url>https://en.wikipedia.org/wiki/Fludeoxyglucose_(18F)</url>
      </link>
    </links>
  </general-references>
  <synthesis-reference/>
  <indication>The uptake of 18F-FDG by tissues is a marker for the tissue uptake of glucose, which in turn is closely correlated with certain types of tissue metabolism.&#13;
Fludeoxyglucose F 18 Injection is indicated in positron emission tomography (PET) imaging for assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnoses of cancer. </indication>
  <pharmacodynamics>Fludeoxyglucose F 18 Injection is rapidly distributed to all organs of the body after intravenous administration. After background clearance of Fludeoxyglucose F 18 Injection, optimal PET imaging is generally achieved between 30 to 40 minutes after administration.&#13;
In cancer, the cells are generally characterized by enhanced glucose metabolism partially due to (1) an increase in the activity of glucose transporters, (2) an increased rate of phosphorylation activity, (3) a reduction of phosphatase activity or, (4) a dynamic alteration in the balance among all these&#13;
processes. However, glucose metabolism of cancer as reflected by Fludeoxyglucose F 18 accumulation shows considerable variability. Depending on tumor type, stage, and location, Fludeoxyglucose F 18 accumulation may be increased, normal, or decreased. Also, inflammatory cells can have the same variability of uptake of Fludeoxyglucose F 18.&#13;
In the heart, under normal aerobic conditions, the myocardium meets the bulk of its energy requirements by oxidizing free fatty acids. Most of the exogenous glucose taken up by the myocyte is converted into glycogen. However, under ischemic conditions, the oxidation of free fatty acids decreases, exogenous glucose becomes the preferred myocardial substrate, glycolysis is stimulated, and glucose taken up by the myocyte is metabolized immediately instead of being converted into glycogen. Under these conditions, phosphorylated Fludeoxyglucose F 18 accumulates in the myocyte and can be detected with PET imaging.&#13;
Normally, the brain relies on anaerobic metabolism. In epilepsy, the glucose metabolism varies. Generally, during a seizure glucose metabolism increases. Interictally, the seizure focus tends to be hypometabolic.</pharmacodynamics>
  <mechanism-of-action>Fludeoxyglucose F 18 is a glucose analog that concentrates in cells that rely upon glucose as an energy source, or in cells whose dependence on glucose increases under pathophysiological conditions. Fludeoxyglucose F 18 is transported through the cell membrane by facilitative glucose transporter proteins and is phosphorylated within the cell to [18F] FDG-6- phosphate by the enzyme hexokinase. Once phosphorylated it cannot exit until it is dephosphorylated by glucose-6-phosphatase. Therefore, within a given tissue or pathophysiological process, the retention and clearance of Fludeoxyglucose F 18 reflect a balance involving glucose transporter, hexokinase and glucose-6- phosphatase activities. When allowance is made for the kinetic differences between glucose and Fludeoxyglucose F 18 transport and phosphorylation (expressed as the “lumped constant” ratio), Fludeoxyglucose F 18 is used to assess glucose metabolism.&#13;
In comparison to background activity of the specific organ or tissue type, regions of decreased or absent uptake of Fludeoxyglucose F 18 reflect the decrease or absence of glucose metabolism. Regions of increased uptake of Fludeoxyglucose F 18 reflect greater than normal rates of glucose metabolism. </mechanism-of-action>
  <toxicity>Overdoses of Fludeoxyglucose F 18 Injection have not been reported. </toxicity>
  <metabolism>Fludeoxyglucose F 18 is transported into cells and phosphorylated to [18F]-FDG-6-phosphate at a rate proportional to the rate of glucose utilization within that tissue. [18F]-FDG-6-phosphate presumably is metabolized to 2-deoxy-2-[18F] fluoro-6-phospho-Dmannose ([18F]FDM-6-phosphate).&#13;
Fludeoxyglucose F 18 Injection may contain several impurities (e.g., 2-deoxy-2-chloro-D-glucose (ClDG)). Biodistribution and metabolism of C1DG are presumed to be similar to Fludeoxyglucose F 18 and would be expected to result in intracellular formation of 2-deoxy-2-chloro-6-phospho-D-glucose (C1DG-6-phosphate) and 2-deoxy-2-chloro-6-phospho-D-mannose (ClDM-6-phosphate). The phosphorylated deoxyglucose compounds are dephosphorylated and the resulting compounds (FDG, FDM, C1DG, and ClDM) presumably leave cells by passive diffusion. </metabolism>
  <absorption>Fludeoxyglucose F 18 Injection is rapidly distributed to all organs of the body after intravenous administration.</absorption>
  <half-life>10-13 minutes</half-life>
  <protein-binding>The extent of binding of Fludeoxyglucose F 18 to plasma proteins is not known. </protein-binding>
  <route-of-elimination>Fludeoxyglucose F 18 is cleared from most tissues within 24 hours and can be eliminated from the body unchanged in the urine.</route-of-elimination>
  <volume-of-distribution>Fludeoxyglucose F 18 Injection is rapidly distributed to all organs of the body after intravenous administration.</volume-of-distribution>
  <clearance>Fludeoxyglucose F 18 and related compounds are cleared from non-cardiac tissues within 3 to 24 hours after administration. Clearance from the cardiac tissue may require more than 96 hours</clearance>
  <salts/>
  <synonyms/>
  <products>
    <product>
      <name>Fludeoxyglucose F 18</name>
      <labeller>The University Of Utah Dba Cyclotron Radiochemistry Lab Huntsman Cancer Institute</labeller>
      <ndc-id/>
      <ndc-product-code>67939-010</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-11-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA204498</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F 18</name>
      <labeller>Washington University School Of Medicine</labeller>
      <ndc-id/>
      <ndc-product-code>75913-647</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-01-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203935</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F 18</name>
      <labeller>Triad Isotopes, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>60055-334</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-11-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203920</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F 18</name>
      <labeller>Mayo Clinic</labeller>
      <ndc-id/>
      <ndc-product-code>52670-551</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-08-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>240 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203612</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F 18</name>
      <labeller>Hamamatsu/Queen?S Pet Imaging Center, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>76376-618</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-11-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>100 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203771</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F 18</name>
      <labeller>Petnet Solutions, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>40028-511</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2008-07-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>200 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA079086</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F 18</name>
      <labeller>Uihc P E T Imaging Center</labeller>
      <ndc-id/>
      <ndc-product-code>24417-001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203990</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F 18</name>
      <labeller>University Of California, Los Angeles</labeller>
      <ndc-id/>
      <ndc-product-code>76394-3811</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-06-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>40 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203811</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F 18</name>
      <labeller>Hot Shots Nm, Llc Dba Midwest Positron Technology, Lc</labeller>
      <ndc-id/>
      <ndc-product-code>76419-111</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-08-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>500 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203937</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F 18</name>
      <labeller>Global Isotopes, Llc D/B/A Zevacor Molecular</labeller>
      <ndc-id/>
      <ndc-product-code>69126-003</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-10-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>20 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA204463</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F 18</name>
      <labeller>Ncm Usa Bronx Llc</labeller>
      <ndc-id/>
      <ndc-product-code>24445-334</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-01-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA204512</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F 18</name>
      <labeller>Massachusetts General Hospital</labeller>
      <ndc-id/>
      <ndc-product-code>76318-334</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-10-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA204333</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F 18</name>
      <labeller>Centre For Probe Development And Commercialization</labeller>
      <ndc-id/>
      <ndc-product-code>21731-647</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA204525</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F 18</name>
      <labeller>Zevacor Pharma, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>49609-101</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203591</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F 18</name>
      <labeller>Spectron Mrc, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>13108-111</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-04-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>500 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203911</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F 18</name>
      <labeller>Children's Hospital Of Michigan</labeller>
      <ndc-id/>
      <ndc-product-code>76167-001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-11-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA204385</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F-18</name>
      <labeller>Shertech Laboratories, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>16129-001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2006-03-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA204264</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F-18</name>
      <labeller>Brigham And Women`s Hospital, Inc., The</labeller>
      <ndc-id/>
      <ndc-product-code>24450-647</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-10-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203816</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F-18</name>
      <labeller>University Of North Dakota</labeller>
      <ndc-id/>
      <ndc-product-code>24468-001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-09-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>500 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203994</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F-18</name>
      <labeller>Precision Nuclear Llc</labeller>
      <ndc-id/>
      <ndc-product-code>52768-001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-10-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>500 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA204546</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F-18</name>
      <labeller>Trustees Of The University Of Pennsylvania</labeller>
      <ndc-id/>
      <ndc-product-code>40098-101</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>200 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203801</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F-18</name>
      <labeller>Cardinal Health 414, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>65857-100</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-11-13</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203603</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F-18</name>
      <labeller>Lantheus Medical Imaging</labeller>
      <ndc-id/>
      <ndc-product-code>11994-015</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-02-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>200 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203664</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F18</name>
      <labeller>University Of Texas Md Anderson Cancer Center</labeller>
      <ndc-id/>
      <ndc-product-code>60215-411</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203246</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F18</name>
      <labeller>Ucsf Radiopharmaceutical Facility</labeller>
      <ndc-id/>
      <ndc-product-code>24275-0185</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203902</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F18</name>
      <labeller>Cyclotron Partners Lp Dba Cyclotope</labeller>
      <ndc-id/>
      <ndc-product-code>47584-001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>500 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203665</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F18</name>
      <labeller>Wisconsin Medical Cyclotron, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>44338-001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>500 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203709</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F18</name>
      <labeller>The Regents of the University of Michigan</labeller>
      <ndc-id/>
      <ndc-product-code>76326-001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-06-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA204531</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F18</name>
      <labeller>Mips Cyclotron &amp; Radiochemistry Facility</labeller>
      <ndc-id/>
      <ndc-product-code>69587-001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-02-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA204472</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F18</name>
      <labeller>Biomedical Research Foundation Of Northwest Louisiana</labeller>
      <ndc-id/>
      <ndc-product-code>24562-001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-05-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203710</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F18</name>
      <labeller>Biomedical Research Foundation Of Northwest Louisiana</labeller>
      <ndc-id/>
      <ndc-product-code>24562-003</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-05-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203837</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F18</name>
      <labeller>Essential Isotopes</labeller>
      <ndc-id/>
      <ndc-product-code>51760-001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2005-08-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203946</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F18</name>
      <labeller>Memorial Sloan Kettering Cancer Center</labeller>
      <ndc-id/>
      <ndc-product-code>69815-754</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-04-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA208679</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F18</name>
      <labeller>Feinstein Institute For Medical Research</labeller>
      <ndc-id/>
      <ndc-product-code>13267-123</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2005-08-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>300 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>NDA021870</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F18</name>
      <labeller>Feinstein Institute For Medical Research</labeller>
      <ndc-id/>
      <ndc-product-code>13267-234</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2005-08-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>400 mCi/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>NDA021870</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Fludeoxyglucose F18</name>
      <labeller>The Methodist Hospital Research Institute</labeller>
      <ndc-id/>
      <ndc-product-code>69864-001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-04-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>.3 Ci/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA203904</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Fludeoxyglucose F-18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F 18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F-18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F 18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F 18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F-18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F-18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F 18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F-18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F 18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F-18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F 18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F 18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F 18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F 18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F 18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F 18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F 18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F 18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F 18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F 18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F 18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F-18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
    <mixture>
      <name>Fludeoxyglucose F18</name>
      <ingredients>Fludeoxyglucose F-18</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories/>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>20 mCi/mL</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>240 mCi/mL</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>40 mCi/mL</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>500 mCi/mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>100 mCi/mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>200 mCi/mL</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>200 mCi/mL</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>300 mCi/mL</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>400 mCi/mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>.3 Ci/mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>300 mCi/mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>500 mCi/mL</strength>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties/>
  <experimental-properties/>
  <external-identifiers/>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes>
    <enzyme position="1">
      <id>BE0001108</id>
      <name>Hexokinase-1</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles/>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="P19367" source="Swiss-Prot">
    <name>Hexokinase-1</name>
    <general-function>Mannokinase activity</general-function>
    <specific-function/>
    <gene-name>HK1</gene-name>
    <locus>10q22</locus>
    <cellular-location>Mitochondrion outer membrane</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.78</theoretical-pi>
    <molecular-weight>102485.1</molecular-weight>
    <chromosome-location>10</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4922</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>HK1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M75126</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>184021</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P19367</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>HXK1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.7.1.1</synonym>
      <synonym>Brain form hexokinase</synonym>
      <synonym>Hexokinase type I</synonym>
      <synonym>HK I</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0002205|Hexokinase-1
MIAAQLLAYYFTELKDDQVKKIDKYLYAMRLSDETLIDIMTRFRKEMKNGLSRDFNPTAT
VKMLPTFVRSIPDGSEKGDFIALDLGGSSFRILRVQVNHEKNQNVHMESEVYDTPENIVH
GSGSQLFDHVAECLGDFMEKRKIKDKKLPVGFTFSFPCQQSKIDEAILITWTKRFKASGV
EGADVVKLLNKAIKKRGDYDANIVAVVNDTVGTMMTCGYDDQHCEVGLIIGTGTNACYME
ELRHIDLVEGDEGRMCINTEWGAFGDDGSLEDIRTEFDREIDRGSLNPGKQLFEKMVSGM
YLGELVRLILVKMAKEGLLFEGRITPELLTRGKFNTSDVSAIEKNKEGLHNAKEILTRLG
VEPSDDDCVSVQHVCTIVSFRSANLVAATLGAILNRLRDNKGTPRLRTTVGVDGSLYKTH
PQYSRRFHKTLRRLVPDSDVRFLLSESGSGKGAAMVTAVAYRLAEQHRQIEETLAHFHLT
KDMLLEVKKRMRAEMELGLRKQTHNNAVVKMLPSFVRRTPDGTENGDFLALDLGGTNFRV
LLVKIRSGKKRTVEMHNKIYAIPIEIMQGTGEELFDHIVSCISDFLDYMGIKGPRMPLGF
TFSFPCQQTSLDAGILITWTKGFKATDCVGHDVVTLLRDAIKRREEFDLDVVAVVNDTVG
TMMTCAYEEPTCEVGLIVGTGSNACYMEEMKNVEMVEGDQGQMCINMEWGAFGDNGCLDD
IRTHYDRLVDEYSLNAGKQRYEKMISGMYLGEIVRNILIDFTKKGFLFRGQISETLKTRG
IFETKFLSQIESDRLALLQVRAILQQLGLNSTCDDSILVKTVCGVVSRRAAQLCGAGMAA
VVDKIRENRGLDRLNVTVGVDGTLYKLHPHFSRIMHQTVKELSPKCNVSFLLSEDGSGKG
AALITAVGVRLRTEASS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016317|Hexokinase-1 (HK1)
ATGATCGCCGCGCAGCTCCTGGCCTATTACTTCACGGAGCTGAAGGATGACCAGGTCAAA
AAGATTGACAAGTATCTCTATGCCATGCGGCTCTCCGATGAAACTCTCATAGATATCATG
ACTCGCTTCAGGAAGGAGATGAAGAATGGCCTCTCCCGGGATTTTAATCCAACAGCCACA
GTCAAGATGTTGCCAACATTCGTAAGGTCCATTCCTGATGGCTCTGAAAAGGGAGATTTC
ATTGCCCTGGATCTTGGTGGGTCTTCCTTTCGAATTCTGCGGGTGCAAGTGAATCATGAG
AAAAACCAGAATGTTCACATGGAGTCCGAGGTTTATGACACCCCAGAGAACATCGTGCAC
GGCAGTGGAAGCCAGCTTTTTGATCATGTTGCTGAGTGCCTGGGAGATTTCATGGAGAAA
AGGAAGATCAAGGACAAGAAGTTACCTGTGGGATTCACGTTTTCTTTTCCTTGCCAACAA
TCCAAAATAGATGAGGCCATCCTGATCACCTGGACAAAGCGATTTAAAGCGAGCGGAGTG
GAAGGAGCAGATGTGGTCAAACTGCTTAACAAAGCCATCAAAAAGCGAGGGGACTATGAT
GCCAACATCGTAGCTGTGGTGAATGACACAGTGGGCACCATGATGACCTGTGGCTATGAC
GACCAGCACTGTGAAGTCGGCCTGATCATCGGCACTGGCACCAATGCTTGCTACATGGAG
GAACTGAGGCACATTGATCTGGTGGAAGGAGACGAGGGGAGGATGTGTATCAATACAGAA
TGGGGAGCCTTTGGAGACGATGGATCATTAGAAGACATCCGGACAGAGTTTGACAGGGAG
ATAGACCGGGGATCCCTCAACCCTGGAAAACAGCTGTTTGAGAAGATGGTCAGTGGCATG
TACTTGGGAGAGCTGGTTCGACTGATCCTAGTCAAGATGGCCAAGGAGGGCCTCTTATTT
GAAGGGCGGATCACCCCGGAGCTGCTCACCCGAGGGAAGTTTAACACCAGTGATGTGTCA
GCCATCGAAAAGAATAAGGAAGGCCTCCACAATGCCAAAGAAATCCTGACCCGCCTGGGA
GTGGAGCCGTCCGATGATGACTGTGTCTCAGTCCAGCACGTTTGCACCATTGTCTCATTT
CGCTCAGCCAACTTGGTGGCTGCCACACTGGGCGCCATCTTGAACCGCCTGCGTGATAAC
AAGGGCACACCCAGGCTGCGGACCACGGTTGGTGTCGACGGATCTCTTTACAAGACGCAC
CCACAGTATTCCCGGCGTTTCCACAAGACTCTAAGGCGCTTGGTGCCAGACTCCGATGTG
CGCTTCCTCCTCTCGGAGAGTGGCAGCGGCAAGGGGGCTGCCATGGTGACGGCGGTGGCC
TACCGCTTGGCCGAGCAGCACCGGCAGATAGAGGAGACCCTGGCTCATTTCCACCTCACC
AAGGACATGCTGCTGGAGGTGAAGAAGAGGATGCGGGCCGAGATGGAGCTGGGGCTGAGG
AAGCAGACGCACAACAATGCCGTGGTTAAGATGCTGCCCTCCTTCGTCCGGAGAACTCCC
GACGGGACCGAGAATGGTGACTTCTTGGCCCTGGATCTTGGAGGAACCAATTTCCGTGTG
CTGCTGGTGAAAATCCGTAGTGGGAAAAAGAGAACGGTGGAAATGCACAACAAGATCTAC
GCCATTCCTATTGAAATCATGCAGGGCACTGGGGAAGAGCTGTTTGATCACATTGTCTCC
TGCATCTCTGACTTCTTGGACTACATGGGGATCAAAGGCCCCAGGATGCCTCTGGGCTTC
ACGTTCTCATTTCCCTGCCAGCAGACGAGTCTGGACGCGGGAATCTTGATCACGTGGACA
AAGGGTTTTAAGGCAACAGACTGCGTGGGCCACGATGTAGTCACCTTACTAAGGGATGCG
ATAAAAAGGAGAGAGGAATTTGACCTGGACGTGGTGGCTGTGGTCAACGACACAGTGGGC
ACCATGATGACCTGTGCTTATGAGGAGCCCACCTGTGAGGTTGGACTCATTGTTGGGACC
GGCAGCAATGCCTGCTACATGGAGGAGATGAAGAACGTGGAGATGGTGGAGGGGGACCAG
GGGCAGATGTGCATCAACATGGAGTGGGGGGCCTTTGGGGACAACGGGTGTCTGGATGAT
ATCAGGACACACTACGACAGACTGGTGGACGAATATTCCCTAAATGCTGGGAAACAAAGG
TATGAGAAGATGATCAGTGGTATGTACCTGGGTGAAATCGTCCGCAACATCTTAATCGAC
TTCACCAAGAAGGGATTCCTCTTCCGAGGGCAGATCTCTGAGACGCTGAAGACCCGGGGC
ATCTTTGAGACCAAGTTTCTCTCTCAGATCGAGAGTGACCGATTAGCACTGCTCCAGGTC
CGGGCTATCCTCCAGCAGCTAGGTCTGAATAGCACCTGCGATGACAGTATCCTCGTCAAG
ACAGTGTGCGGGGTGGTGTCCAGGAGGGCCGCACAGCTGTGTGGCGCAGGCATGGCTGCG
GTTGTGGATAAGATCCGCGAGAACAGAGGACTGGACCGTCTGAATGTGACTGTGGGAGTG
GACGGGACACTCTACAAGCTTCATCCACACTTCTCCAGAATCATGCACCAGACGGTGAAG
GAACTGTCACCAAAATGTAACGTGTCCTTCCTCCTGTCTGAGGATGGCAGCGGCAAGGGG
GCCGCCCTCATCACGGCCGTGGGCGTGCGGTTACGCACAGAGGCAAGCAGCTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00349</identifier>
        <name>Hexokinase_1</name>
      </pfam>
      <pfam>
        <identifier>PF03727</identifier>
        <name>Hexokinase_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial outer membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glucokinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>fructokinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glucose binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>mannokinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>hexokinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>hexose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose 6-phosphate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>establishment of protein localization to mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>maintenance of protein location in mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glycolytic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>canonical glycolysis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular glucose homeostasis</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
  </enzymes>
  <carriers/>
  <transporters>
    <transporter position="2">
      <id>BE0000893</id>
      <name>Solute carrier family 2, facilitated glucose transporter member 4</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles/>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="P14672" source="Swiss-Prot">
    <name>Solute carrier family 2, facilitated glucose transporter member 4</name>
    <general-function>Glucose transmembrane transporter activity</general-function>
    <specific-function>Insulin-regulated facilitative glucose transporter.</specific-function>
    <gene-name>SLC2A4</gene-name>
    <locus>17p13</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>25-45
82-102
112-132
143-163
172-192
202-222
288-308
324-344
354-374
385-405
418-438
446-466</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>6.94</theoretical-pi>
    <molecular-weight>54786.79</molecular-weight>
    <chromosome-location>17</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11009</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC2A4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M20747</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>307076</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P14672</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GTR4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Glucose transporter type 4, insulin-responsive</synonym>
      <synonym>GLUT-4</synonym>
      <synonym>GLUT4</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001780|Solute carrier family 2, facilitated glucose transporter member 4
MPSGFQQIGSEDGEPPQQRVTGTLVLAVFSAVLGSLQFGYNIGVINAPQKVIEQSYNETW
LGRQGPEGPSSIPPGTLTTLWALSVAIFSVGGMISSFLIGIISQWLGRKRAMLVNNVLAV
LGGSLMGLANAAASYEMLILGRFLIGAYSGLTSGLVPMYVGEIAPTHLRGALGTLNQLAI
VIGILIAQVLGLESLLGTASLWPLLLGLTVLPALLQLVLLPFCPESPRYLYIIQNLEGPA
RKSLKRLTGWADVSGVLAELKDEKRKLERERPLSLLQLLGSRTHRQPLIIAVVLQLSQQL
SGINAVFYYSTSIFETAGVGQPAYATIGAGVVNTVFTLVSVLLVERAGRRTLHLLGLAGM
CGCAILMTVALLLLERVPAMSYVSIVAIFGFVAFFEIGPGPIPWFIVAELFSQGPRPAAM
AVAGFSNWTSNFIIGMGFQYVAEAMGPYVFLLFAVLLLGFFIFTFLRVPETRGRTFDQIS
AAFHRTPSLLEQEVKPSTELEYLGPDEND</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016243|Solute carrier family 2, facilitated glucose transporter member 4 (SLC2A4)
ATGCCGTCGGGCTTCCAACAGATAGGCTCCGAAGATGGGGAACCCCCTCAGCAGCGAGTG
ACTGGGACCCTGGTCCTTGCTGTGTTCTCTGCGGTGCTTGGCTCCCTGCAGTTTGGGTAC
AACATTGGGGTCATCAATGCCCCTCAGAAGGTGATTGAACAGAGCTACAATGAGACGTGG
CTGGGGAGGCAGGGGCCTGAGGGACCCAGCTCCATCCCTCCAGGCACCCTCACCACCCTC
TGGGCCCTCTCCGTGGCCATCTTTTCCGTGGGCGGCATGATTTCCTCCTTCCTCATTGGT
ATCATCTCTCAGTGGCTTGGAAGGAAAAGGGCCATGCTGGTCAACAATGTCCTGGCGGTG
CTGGGGGGCAGCCTCATGGGCCTGGCCAATGCTGCTGCCTCCTATGAAATGCTCATCCTT
GGACGATTCCTCATTGGCGCCTACTCAGGGCTGACATCAGGGCTGGTGCCCATGTACGTG
GGGGAGATTGCTCCCACTCACCTGCGGGGCGCCCTGGGGACGCTCAACCAACTGGCCATT
GTTATCGGCATTCTGATCGCCCAGGTGCTGGGCTTGGAGTCCCTCCTGGGCACTGCCAGC
CTGTGGCCACTGCTCCTGGGCCTCACAGTGCTACCTGCCCTCCTGCAGCTGGTCCTGCTG
CCCTTCTGTCCCGAGAGCCCCCGCTACCTCTACATCATCCAGAATCTCGAGGGGCCTGCC
AGAAAGAGTCTGAAGCGCCTGACAGGCTGGGCCGATGTTTCTGGAGTGCTGGCTGAGCTG
AAGGATGAGAAGCGGAAGCTGGAGCGTGAGCGGCCACTGTCCCTGCTCCAGCTCCTGGGC
AGCCGTACCCACCGGCAGCCCCTGATCATTGCGGTCGTGCTGCAGCTGAGCCAGCAGCTC
TCTGGCATCAATGCTGTTTTCTATTATTCGACCAGCATCTTCGAGACAGCAGGGGTAGGC
CAGCCTGCCTATGCCACCATAGGAGCTGGTGTGGTCAACACAGTCTTCACCTTGGTCTCG
GTGTTGTTGGTGGAGCGGGCGGGGCGCCGGACGCTCCATCTCCTGGGCCTGGCGGGCATG
TGTGGCTGTGCCATCCTGATGACTGTGGCTCTGCTCCTGCTGGAGCGAGTTCCAGCCATG
AGCTACGTCTCCATTGTGGCCATCTTTGGCTTCGTGGCATTTTTTGAGATTGGCCCTGGC
CCCATTCCTTGGTTCATCGTGGCCGAGCTCTTCAGCCAGGGACCCCGCCCGGCAGCCATG
GCTGTGGCTGGTTTCTCCAACTGGACGAGCAACTTCATCATTGGCATGGGTTTCCAGTAT
GTTGCGGAGGCTATGGGGCCCTACGTCTTCCTTCTATTTGCGGTCCTCCTGCTGGGCTTC
TTCATCTTCACCTTCTTAAGAGTACCTGAAACTCGAGGCCGGACGTTTGACCAGATCTCA
GCTGCCTTCCACCGGACACCCTCTCTTTTAGAGCAGGAGGTGAAACCCAGCACAGAACTT
GAGTATTTAGGGCCAGATGAGAACGACTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00083</identifier>
        <name>Sugar_tr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>trans-Golgi network transport vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>T-tubule</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>vesicle membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>perinuclear region of cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>external side of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>multivesicular body</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>insulin-responsive compartment</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>coated pit</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>clathrin-coated vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane raft</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endomembrane system</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glucose transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>D-glucose transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>hexose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to hypoxia</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to ethanol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amylopectin biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>brown fat cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose import</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>membrane organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to osmotic stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to insulin stimulus</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="3">
      <id>BE0001045</id>
      <name>Solute carrier family 2, facilitated glucose transporter member 2</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles/>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="P11168" source="Swiss-Prot">
    <name>Solute carrier family 2, facilitated glucose transporter member 2</name>
    <general-function>Hexose transmembrane transporter activity</general-function>
    <specific-function>Facilitative glucose transporter. This isoform likely mediates the bidirectional transfer of glucose across the plasma membrane of hepatocytes and is responsible for uptake of glucose by the beta cells; may comprise part of the glucose-sensing mechanism of the beta cell. May also participate with the Na(+)/glucose cotransporter in the transcellular transport of glucose in the small intestine and kidney.</specific-function>
    <gene-name>SLC2A2</gene-name>
    <locus>3q26.1-q26.2</locus>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>11-31
99-119
128-148
159-179
188-208
218-238
304-324
339-359
369-389
401-421
434-454
462-482</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.1</theoretical-pi>
    <molecular-weight>57488.955</molecular-weight>
    <chromosome-location>3</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11006</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC2A2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>J03810</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>307125</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P11168</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GTR2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Glucose transporter type 2, liver</synonym>
      <synonym>GLUT-2</synonym>
      <synonym>GLUT2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0002081|Solute carrier family 2, facilitated glucose transporter member 2
MTEDKVTGTLVFTVITAVLGSFQFGYDIGVINAPQQVIISHYRHVLGVPLDDRKAINNYV
INSTDELPTISYSMNPKPTPWAEEETVAAAQLITMLWSLSVSSFAVGGMTASFFGGWLGD
TLGRIKAMLVANILSLVGALLMGFSKLGPSHILIIAGRSISGLYCGLISGLVPMYIGEIA
PTALRGALGTFHQLAIVTGILISQIIGLEFILGNYDLWHILLGLSGVRAILQSLLLFFCP
ESPRYLYIKLDEEVKAKQSLKRLRGYDDVTKDINEMRKEREEASSEQKVSIIQLFTNSSY
RQPILVALMLHVAQQFSGINGIFYYSTSIFQTAGISKPVYATIGVGAVNMVFTAVSVFLV
EKAGRRSLFLIGMSGMFVCAIFMSVGLVLLNKFSWMSYVSMIAIFLFVSFFEIGPGPIPW
FMVAEFFSQGPRPAALAIAAFSNWTCNFIVALCFQYIADFCGPYVFFLFAGVLLAFTLFT
FFKVPETKGKSFEEIAAEFQKKSGSAHRPKAAVEMKFLGATETV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020501|Solute carrier family 2, facilitated glucose transporter member 2 (SLC2A2)
ATGACAGAAGATAAGGTCACTGGGACCCTGGTTTTCACTGTCATCACTGCTGTGCTGGGT
TCCTTCCAGTTTGGATATGACATTGGTGTGATCAATGCACCTCAACAGGTAATAATATCT
CACTATAGACATGTTTTGGGTGTTCCACTGGATGACCGAAAAGCTATCAACAACTATGTT
ATCAACAGTACAGATGAACTGCCCACAATCTCATACTCAATGAACCCAAAACCAACCCCT
TGGGCTGAGGAAGAGACTGTGGCAGCTGCTCAACTAATCACCATGCTCTGGTCCCTGTCT
GTATCCAGCTTTGCAGTTGGTGGAATGACTGCATCATTCTTTGGTGGGTGGCTTGGGGAC
ACACTTGGAAGAATCAAAGCCATGTTAGTAGCAAACATTCTGTCATTAGTTGGAGCTCTC
TTGATGGGGTTTTCAAAATTGGGACCATCTCATATACTTATAATTGCTGGAAGAAGCATA
TCAGGACTATATTGTGGGCTAATTTCAGGCCTGGTTCCTATGTATATCGGTGAAATTGCT
CCAACCGCTCTCAGGGGAGCACTTGGCACTTTTCATCAGCTGGCCATCGTCACGGGCATT
CTTATTAGTCAGATTATTGGTCTTGAATTTATCTTGGGCAATTATGATCTGTGGCACATC
CTGCTTGGCCTGTCTGGTGTGCGAGCCATCCTTCAGTCTCTGCTACTCTTTTTCTGTCCA
GAAAGCCCCAGATACCTTTACATCAAGTTAGATGAGGAAGTCAAAGCAAAACAAAGCTTG
AAAAGACTCAGAGGATATGATGATGTCACCAAAGATATTAATGAAATGAGAAAAGAAAGA
GAAGAAGCATCGAGTGAGCAGAAAGTCTCTATAATTCAGCTCTTCACCAATTCCAGCTAC
CGACAGCCTATTCTAGTGGCACTGATGCTGCATGTGGCTCAGCAATTTTCCGGAATCAAT
GGCATTTTTTACTACTCAACCAGCATTTTTCAGACGGCTGGTATCAGCAAACCTGTTTAT
GCAACCATTGGAGTTGGCGCTGTAAACATGGTTTTCACTGCTGTCTCTGTATTCCTTGTG
GAGAAGGCAGGGCGACGTTCTCTCTTTCTAATTGGAATGAGTGGGATGTTTGTTTGTGCC
ATCTTCATGTCAGTGGGACTTGTGCTGCTGAATAAGTTCTCTTGGATGAGTTATGTGAGC
ATGATAGCCATCTTCCTCTTTGTCAGCTTCTTTGAAATTGGGCCAGGCCCGATCCCCTGG
TTCATGGTGGCTGAGTTTTTCAGTCAAGGACCACGTCCTGCTGCTTTAGCAATAGCTGCA
TTCAGCAATTGGACCTGCAATTTCATTGTAGCTCTGTGTTTCCAGTACATTGCGGACTTC
TGTGGACCTTATGTGTTTTTCCTCTTTGCTGGAGTGCTCCTGGCCTTTACCCTGTTCACA
TTTTTTAAAGTTCCAGAAACCAAAGGAAAGTCTTTTGAGGAAATTGCTGCAGAATTCCAA
AAGAAGAGTGGCTCAGCCCACAGGCCAAAAGCTGCTGTAGAAATGAAATTCCTAGGAGCT
ACAGAGACTGTGTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00083</identifier>
        <name>Sugar_tr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>basolateral plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>brush border membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell-cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glucose transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>D-glucose transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>dehydroascorbic acid transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>hexose transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to glucose</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to peptide hormone</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate utilization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fructose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>energy reserve metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>hexose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of insulin secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>hexose transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>endocrine pancreas development</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="4">
      <id>BE0001057</id>
      <name>Solute carrier family 2, facilitated glucose transporter member 1</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles/>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="P11166" source="Swiss-Prot">
    <name>Solute carrier family 2, facilitated glucose transporter member 1</name>
    <general-function>Xenobiotic transporter activity</general-function>
    <specific-function>Facilitative glucose transporter. This isoform may be responsible for constitutive or basal glucose uptake. Has a very broad substrate specificity; can transport a wide range of aldoses including both pentoses and hexoses.</specific-function>
    <gene-name>SLC2A1</gene-name>
    <locus>1p35-p31.3</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>12-33
67-87
91-112
121-144
156-176
186-206
272-293
307-328
335-355
366-388
402-422
430-450</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.91</theoretical-pi>
    <molecular-weight>54083.325</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11005</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC2A1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>K03195</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>183303</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P11166</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GTR1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Glucose transporter type 1, erythrocyte/brain</synonym>
      <synonym>GLUT-1</synonym>
      <synonym>GLUT1</synonym>
      <synonym>HepG2 glucose transporter</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016298|Solute carrier family 2, facilitated glucose transporter member 1
MEPSSKKLTGRLMLAVGGAVLGSLQFGYNTGVINAPQKVIEEFYNQTWVHRYGESILPTT
LTTLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLMMNLLAFVSAVLMGFSKLGKSFE
MLILGRFIIGVYCGLTTGFVPMYVGEVSPTALRGALGTLHQLGIVVGILIAQVFGLDSIM
GNKDLWPLLLSIIFIPALLQCIVLPFCPESPRFLLINRNEENRAKSVLKKLRGTADVTHD
LQEMKEESRQMMREKKVTILELFRSPAYRQPILIAVVLQLSQQLSGINAVFYYSTSIFEK
AGVQQPVYATIGSGIVNTAFTVVSLFVVERAGRRTLHLIGLAGMAGCAILMTIALALLEQ
LPWMSYLSIVAIFGFVAFFEVGPGPIPWFIVAELFSQGPRPAAIAVAGFSNWTSNFIVGM
CFQYVEQLCGPYVFIIFTVLLVLFFIFTYFKVPETKGRTFDEIASGFRQGGASQSDKTPE
ELFHPLGADSQV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016299|Solute carrier family 2, facilitated glucose transporter member 1 (SLC2A1)
ATGGAGCCCAGCAGCAAGAAGCTGACGGGTCGCCTCATGCTGGCCGTGGGAGGAGCAGTG
CTTGGCTCCCTGCAGTTTGGCTACAACACTGGAGTCATCAATGCCCCCCAGAAGGTGATC
GAGGAGTTCTACAACCAGACATGGGTCCACCGCTATGGGGAGAGCATCCTGCCCACCACG
CTCACCACGCTCTGGTCCCTCTCAGTGGCCATCTTTTCTGTTGGGGGCATGATTGGCTCC
TTCTCTGTGGGCCTTTTCGTTAACCGCTTTGGCCGGCGGAATTCAATGCTGATGATGAAC
CTGCTGGCCTTCGTGTCCGCCGTGCTCATGGGCTTCTCGAAACTGGGCAAGTCCTTTGAG
ATGCTGATCCTGGGCCGCTTCATCATCGGTGTGTACTGCGGCCTGACCACAGGCTTCGTG
CCCATGTATGTGGGTGAAGTGTCACCCACAGCCCTTCGTGGGGCCCTGGGCACCCTGCAC
CAGCTGGGCATCGTCGTCGGCATCCTCATCGCCCAGGTGTTCGGCCTGGACTCCATCATG
GGCAACAAGGACCTGTGGCCCCTGCTGCTGAGCATCATCTTCATCCCGGCCCTGCTGCAG
TGCATCGTGCTGCCCTTCTGCCCCGAGAGTCCCCGCTTCCTGCTCATCAACCGCAACGAG
GAGAACCGGGCCAAGAGTGTGCTAAAGAAGCTGCGCGGGACAGCTGACGTGACCCATGAC
CTGCAGGAGATGAAGGAAGAGAGTCGGCAGATGATGCGGGAGAAGAAGGTCACCATCCTG
GAGCTGTTCCGCTCCCCCGCCTACCGCCAGCCCATCCTCATCGCTGTGGTGCTGCAGCTG
TCCCAGCAGCTGTCTGGCATCAACGCTGTCTTCTATTACTCCACGAGCATCTTCGAGAAG
GCGGGGGTGCAGCAGCCTGTGTATGCCACCATTGGCTCCGGTATCGTCAACACGGCCTTC
ACTGTCGTGTCGCTGTTTGTGGTGGAGCGAGCAGGCCGGCGGACCCTGCACCTCATAGGC
CTCGCTGGCATGGCGGGTTGTGCCATACTCATGACCATCGCGCTAGCACTGCTGGAGCAG
CTACCCTGGATGTCCTATCTGAGCATCGTGGCCATCTTTGGCTTTGTGGCCTTCTTTGAA
GTGGGTCCTGGCCCCATCCCATGGTTCATCGTGGCTGAACTCTTCAGCCAGGGTCCACGT
CCAGCTGCCATTGCCGTTGCAGGCTTCTCCAACTGGACCTCAAATTTCATTGTGGGCATG
TGCTTCCAGTATGTGGAGCAACTGTGTGGTCCCTACGTCTTCATCATCTTCACTGTGCTC
CTGGTTCTGTTCTTCATCTTCACCTACTTCAAAGTTCCTGAGACTAAAGGCCGGACCTTC
GATGAGATCGCTTCCGGCTTCCGGCAGGGGGGAGCCAGCCAAAGTGACAAGACACCCGAG
GAGCTGTTCCATCCCCTGGGGGCTGATTCCCAAGTGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00083</identifier>
        <name>Sugar_tr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>caveola</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>midbody</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cortical actin cytoskeleton</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>female pronucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>basolateral plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>melanosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell-cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>blood microparticle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>dehydroascorbic acid transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>identical protein binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glucose transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>D-glucose transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>xenobiotic transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein self-association</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lactose biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>water-soluble vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>hexose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-ascorbic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to glucose starvation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>energy reserve metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein complex assembly</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of insulin secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to osmotic stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="5">
      <id>BE0004707</id>
      <name>Solute carrier family 2, facilitated glucose transporter member 3</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles/>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="P11169" source="Swiss-Prot">
    <name>Solute carrier family 2, facilitated glucose transporter member 3</name>
    <general-function>Glucose transmembrane transporter activity</general-function>
    <specific-function>Facilitative glucose transporter that can also mediate the uptake of various other monosaccharides across the cell membrane (PubMed:9477959, PubMed:26176916). Mediates the uptake of glucose, 2-deoxyglucose, galactose, mannose, xylose and fucose, and probably also dehydroascorbate (PubMed:9477959, PubMed:26176916). Does not mediate fructose transport (PubMed:9477959, PubMed:26176916).</specific-function>
    <gene-name>SLC2A3</gene-name>
    <locus/>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>11-32
65-85
91-111
119-142
154-174
184-204
270-290
305-325
332-352
364-389
400-420
430-450</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi/>
    <molecular-weight>53923.785</molecular-weight>
    <chromosome-location>12</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11007</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P11169</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GTR3_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Glucose transporter type 3, brain</synonym>
      <synonym>GLUT-3</synonym>
      <synonym>GLUT3</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0017515|Solute carrier family 2, facilitated glucose transporter member 3
MGTQKVTPALIFAITVATIGSFQFGYNTGVINAPEKIIKEFINKTLTDKGNAPPSEVLLT
SLWSLSVAIFSVGGMIGSFSVGLFVNRFGRRNSMLIVNLLAVTGGCFMGLCKVAKSVEML
ILGRLVIGLFCGLCTGFVPMYIGEISPTALRGAFGTLNQLGIVVGILVAQIFGLEFILGS
EELWPLLLGFTILPAILQSAALPFCPESPRFLLINRKEEENAKQILQRLWGTQDVSQDIQ
EMKDESARMSQEKQVTVLELFRVSSYRQPIIISIVLQLSQQLSGINAVFYYSTGIFKDAG
VQEPIYATIGAGVVNTIFTVVSLFLVERAGRRTLHMIGLGGMAFCSTLMTVSLLLKDNYN
GMSFVCIGAILVFVAFFEIGPGPIPWFIVAELFSQGPRPAAMAVAGCSNWTSNFLVGLLF
PSAAHYLGAYVFIIFTGFLITFLAFTFFKVPETRGRTFEDITRAFEGQAHGADRSGKDGV
MEMNSIEPAKETTTNV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0017516|Solute carrier family 2, facilitated glucose transporter member 3 (SLC2A3)
ATGGGGACACAGAAGGTCACCCCAGCTCTGATATTTGCCATCACAGTTGCTACAATCGGC
TCTTTCCAATTTGGCTACAACACTGGGGTCATCAATGCTCCTGAGAAGATCATAAAGGAA
TTTATCAATAAAACTTTGACGGACAAGGGAAATGCCCCACCCTCTGAGGTGCTGCTCACG
TCTCTCTGGTCCTTGTCTGTGGCCATATTTTCCGTCGGGGGTATGATCGGCTCCTTTTCC
GTCGGACTCTTCGTCAACCGCTTTGGCAGGCGCAATTCAATGCTGATTGTCAACCTGTTG
GCTGTCACTGGTGGCTGCTTTATGGGACTGTGTAAAGTAGCTAAGTCGGTTGAAATGCTG
ATCCTGGGTCGCTTGGTTATTGGCCTCTTCTGCGGACTCTGCACAGGTTTTGTGCCCATG
TACATTGGAGAGATCTCGCCTACTGCCCTGCGGGGTGCCTTTGGCACTCTCAACCAGCTG
GGCATCGTTGTTGGAATTCTGGTGGCCCAGATCTTTGGTCTGGAATTCATCCTTGGGTCT
GAAGAGCTATGGCCGCTGCTACTGGGTTTTACCATCCTTCCTGCTATCCTACAAAGTGCA
GCCCTTCCATTTTGCCCTGAAAGTCCCAGATTTTTGCTCATTAACAGAAAAGAAGAGGAG
AATGCTAAGCAGATCCTCCAGCGGTTGTGGGGCACCCAGGATGTATCCCAAGACATCCAG
GAGATGAAAGATGAGAGTGCAAGGATGTCACAAGAAAAGCAAGTCACCGTGCTAGAGCTC
TTTAGAGTGTCCAGCTACCGACAGCCCATCATCATTTCCATTGTGCTCCAGCTCTCTCAG
CAGCTCTCTGGGATCAATGCTGTGTTCTATTACTCAACAGGAATCTTCAAGGATGCAGGT
GTTCAAGAGCCCATCTATGCCACCATCGGCGCGGGTGTGGTTAATACTATCTTCACTGTA
GTTTCTCTATTTCTGGTGGAAAGGGCAGGAAGAAGGACTCTGCATATGATAGGCCTTGGA
GGGATGGCTTTTTGTTCCACGCTCATGACTGTTTCTTTGTTATTAAAGGATAACTATAAT
GGGATGAGCTTTGTCTGTATTGGGGCTATCTTGGTCTTTGTAGCCTTCTTTGAAATTGGA
CCAGGCCCCATTCCCTGGTTTATTGTGGCCGAACTCTTCAGCCAGGGCCCCCGCCCAGCT
GCGATGGCAGTGGCCGGCTGCTCCAACTGGACCTCCAACTTCCTAGTCGGATTGCTCTTC
CCCTCCGCTGCTCACTATTTAGGAGCCTACGTTTTTATTATCTTCACCGGCTTCCTCATT
ACCTTCTTGGCTTTTACCTTCTTCAAAGTCCCTGAGACCCGTGGCAGGACTTTTGAGGAT
ATCACACGGGCCTTTGAAGGGCAGGCACACGGTGCAGATAGATCTGGAAAGGACGGCGTC
ATGGAGATGAACAGCATCGAGCCTGCTAAGGAGACCACCACCAATGTCTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00083</identifier>
        <name>Sugar_tr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glucose transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glucose binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>water-soluble vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-ascorbic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>hexose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transmembrane transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="6">
      <id>BE0004783</id>
      <name>Solute carrier family 2, facilitated glucose transporter member 9</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles/>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="Q9NRM0" source="Swiss-Prot">
    <name>Solute carrier family 2, facilitated glucose transporter member 9</name>
    <general-function>Sugar:proton symporter activity</general-function>
    <specific-function>Transport urate and fructose. May have a role in the urate reabsorption by proximal tubules. Also transports glucose at low rate.</specific-function>
    <gene-name>SLC2A9</gene-name>
    <locus/>
    <cellular-location>Basolateral cell membrane</cellular-location>
    <transmembrane-regions>52-72
108-128
141-161
172-192
201-221
232-252
317-337
355-375
382-402
416-436
452-472
479-499</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi/>
    <molecular-weight>58701.205</molecular-weight>
    <chromosome-location>4</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:13446</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9NRM0</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GTR9_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Glucose transporter type 9</synonym>
      <synonym>GLUT-9</synonym>
      <synonym>GLUT9</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0008632|Solute carrier family 2, facilitated glucose transporter member 9
MARKQNRNSKELGLVPLTDDTSHAGPPGPGRALLECDHLRSGVPGGRRRKDWSCSLLVAS
LAGAFGSSFLYGYNLSVVNAPTPYIKAFYNESWERRHGRPIDPDTLTLLWSVTVSIFAIG
GLVGTLIVKMIGKVLGRKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGV
ALSVLPMYLSEISPKEIRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVV
PAVVQLLSLPFLPDSPRYLLLEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIR
LVSVLELLRAPYVRWQVVTVIVTMACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLST
GGIETLAAVFSGLVIEHLGRRPLLIGGFGLMGLFFGTLTITLTLQDHAPWVPYLSIVGIL
AIIASFCSGPGGIPFILTGEFFQQSQRPAAFIIAGTVNWLSNFAVGLLFPFIQKSLDTYC
FLVFATICITGAIYLYFVLPETKNRTYAEISQAFSKRNKAYPPEEKIDSAVTDGKINGRP
</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0017534|Solute carrier family 2, facilitated glucose transporter member 9 (SLC2A9)
ATGAAGCTCAGTAAAAAGGACCGAGGAGAAGATGAAGAAAGTGATTCAGCGAAAAAGAAA
TTGGACTGGTCCTGCTCGCTCCTCGTGGCCTCCCTCGCGGGCGCCTTCGGCTCCTCCTTC
CTCTACGGCTACAACCTGTCGGTGGTGAATGCCCCCACCCCGTACATCAAGGCCTTTTAC
AATGAGTCATGGGAAAGAAGGCATGGACGTCCAATAGACCCAGACACTCTGACTTTGCTC
TGGTCTGTGACTGTGTCCATATTCGCCATCGGTGGACTTGTGGGGACGTTAATTGTGAAG
ATGATTGGAAAGGTTCTTGGGAGGAAGCACACTTTGCTGGCCAATAATGGGTTTGCAATT
TCTGCTGCATTGCTGATGGCCTGCTCGCTCCAGGCAGGAGCCTTTGAAATGCTCATCGTG
GGACGCTTCATCATGGGCATAGATGGAGGCGTCGCCCTCAGTGTGCTCCCCATGTACCTT
AGTGAGATCTCACCCAAGGAGATCCGTGGCTCTCTGGGGCAGGTGACTGCCATCTTTATC
TGCATTGGCGTGTTCACTGGGCAGCTTCTGGGCCTGCCCGAGCTGCTGGGAAAGGAGAGT
ACCTGGCCATACCTGTTTGGAGTGATTGTGGTCCCTGCCGTTGTCCAGCTGCTGAGCCTT
CCCTTTCTCCCGGACAGCCCACGCTACCTGCTCTTGGAGAAGCACAACGAGGCAAGAGCT
GTGAAAGCCTTCCAAACGTTCTTGGGTAAAGCAGACGTTTCCCAAGAGGTAGAGGAGGTC
CTGGCTGAGAGCCGCGTGCAGAGGAGCATCCGCCTGGTGTCCGTGCTGGAGCTGCTGAGA
GCTCCCTACGTCCGCTGGCAGGTGGTCACCGTGATTGTCACCATGGCCTGCTACCAGCTC
TGTGGCCTCAATGCAATTTGGTTCTATACCAACAGCATCTTTGGAAAAGCTGGGATCCCT
CCGGCAAAGATCCCATACGTCACCTTGAGTACAGGGGGCATCGAGACTTTGGCTGCCGTC
TTCTCTGGTTTGGTCATTGAGCACCTGGGACGGAGACCCCTCCTCATTGGTGGCTTTGGG
CTCATGGGCCTCTTCTTTGGGACCCTCACCATCACGCTGACCCTGCAGGACCACGCCCCC
TGGGTCCCCTACCTGAGTATCGTGGGCATTCTGGCCATCATCGCCTCTTTCTGCAGTGGG
CCAGGTGGCATCCCGTTCATCTTGACTGGTGAGTTCTTCCAGCAATCTCAGCGGCCGGCT
GCCTTCATCATTGCAGGCACCGTCAACTGGCTCTCCAACTTTGCTGTTGGGCTCCTCTTC
CCATTCATTCAGAAAAGTCTGGACACCTACTGTTTCCTAGTCTTTGCTACAATTTGTATC
ACAGGTGCTATCTACCTGTATTTTGTGCTGCCTGAGACCAAAAACAGAACCTATGCAGAA
ATCAGCCAGGCATTTTCCAAAAGGAACAAAGCATACCCACCAGAAGAGAAAATCGACTCA
GCTGTCACTGATGGTAAGATAAATGGAAGGCCTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00083</identifier>
        <name>Sugar_tr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>basolateral plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>apical plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sugar</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glucose transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>urate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>proton transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="7">
      <id>BE0005216</id>
      <name>Solute carrier family 2, facilitated glucose transporter member 5</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles/>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="P22732" source="Swiss-Prot">
    <name>Solute carrier family 2, facilitated glucose transporter member 5</name>
    <general-function>Glucose transmembrane transporter activity</general-function>
    <specific-function>Cytochalasin B-sensitive carrier. Seems to function primarily as a fructose transporter.</specific-function>
    <gene-name>SLC2A5</gene-name>
    <locus/>
    <cellular-location>Apical cell membrane</cellular-location>
    <transmembrane-regions>13-33
69-89
99-119
121-141
162-182
193-213
278-298
319-339
343-363
369-389
413-433
440-460</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi/>
    <molecular-weight>54973.42</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11010</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P22732</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GTR5_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Fructose transporter</synonym>
      <synonym>Glucose transporter type 5, small intestine</synonym>
      <synonym>GLUT-5</synonym>
      <synonym>GLUT5</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0008980|Solute carrier family 2, facilitated glucose transporter member 5
MEQQDQSMKEGRLTLVLALATLIAAFGSSFQYGYNVAAVNSPALLMQQFYNETYYGRTGE
FMEDFPLTLLWSVTVSMFPFGGFIGSLLVGPLVNKFGRKGALLFNNIFSIVPAILMGCSR
VATSFELIIISRLLVGICAGVSSNVVPMYLGELAPKNLRGALGVVPQLFITVGILVAQIF
GLRNLLANVDGWPILLGLTGVPAALQLLLLPFFPESPRYLLIQKKDEAAAKKALQTLRGW
DSVDREVAEIRQEDEAEKAAGFISVLKLFRMRSLRWQLLSIIVLMGGQQLSGVNAIYYYA
DQIYLSAGVPEEHVQYVTAGTGAVNVVMTFCAVFVVELLGRRLLLLLGFSICLIACCVLT
AALALQDTVSWMPYISIVCVISYVIGHALGPSPIPALLITEIFLQSSRPSAFMVGGSVHW
LSNFTVGLIFPFIQEGLGPYSFIVFAVICLLTTIYIFLIVPETKAKTFIEINQIFTKMNK
VSEVYPEKEELKELPPVTSEQ</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0017662|Solute carrier family 2, facilitated glucose transporter member 5 (SLC2A5)
ATGGAGCAACAGGATCAGAGCATGAAGGAAGGGAGGCTGACGCTTGTGCTTGCCCTGGCA
ACCCTGATAGCTGCCTTTGGGTCATCCTTCCAGTATGGGTACAACGTGGCTGCTGTCAAC
TCCCCAGCACTGCTCATGCAACAATTTTACAATGAGACTTACTATGGTAGGACCGGTGAA
TTCATGGAAGACTTCCCCTTGACGTTGCTGTGGTCTGTAACCGTGTCCATGTTTCCATTT
GGAGGGTTTATCGGATCCCTCCTGGTCGGCCCCTTGGTGAATAAATTTGGCAGAAAAGGG
GCCTTGCTGTTCAACAACATATTTTCTATCGTGCCTGCGATCTTAATGGGATGCAGCAGA
GTCGCCACATCATTTGAGCTTATCATTATTTCCAGACTTTTGGTGGGAATATGTGCAGGT
GTATCTTCCAACGTGGTCCCCATGTACTTAGGGGAGCTGGCCCCTAAAAACCTGCGGGGG
GCTCTCGGGGTGGTGCCCCAGCTCTTCATCACTGTTGGCATCCTTGTGGCCCAGATCTTT
GGTCTTCGGAATCTCCTTGCAAACGTAGATGGTGAGTTCAGGACATCTCGGGAGCACCCC
CACCCCTTCACCACTACCCTTGGCCCCCTCCTTGTGTTCCAAAGCCACCACCACAGGACA
GGACTTTCTGCAGACTGGTCTCTTCTAACAGGCTGGATGTCCTTGGGGGGCCCATCCTGT
CCCGAGCCAACATAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00083</identifier>
        <name>Sugar_tr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>apical plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glucose transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>fructose transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fructose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>hexose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to fructose stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="8">
      <id>BE0005217</id>
      <name>Solute carrier family 2, facilitated glucose transporter member 6</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles/>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="Q9UGQ3" source="Swiss-Prot">
    <name>Solute carrier family 2, facilitated glucose transporter member 6</name>
    <general-function>Glucose transmembrane transporter activity</general-function>
    <specific-function>Facilitative glucose transporter; binds cytochalasin B with low affinity.</specific-function>
    <gene-name>SLC2A6</gene-name>
    <locus/>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>38-58
82-102
112-132
141-161
169-189
195-215
290-310
315-335
340-360
396-416
436-456
463-483</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi/>
    <molecular-weight>54538.55</molecular-weight>
    <chromosome-location>9</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11011</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9UGQ3</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GTR6_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Glucose transporter type 6</synonym>
      <synonym>Glucose transporter type 9</synonym>
      <synonym>GLUT-6</synonym>
      <synonym>GLUT-9</synonym>
      <synonym>GLUT9</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0008981|Solute carrier family 2, facilitated glucose transporter member 6
MQEPLLGAEGPDYDTFPEKPPPSPGDRARVGTLQNKRVFLATFAAVLGNFSFGYALVYTS
PVIPALERSLDPDLHLTKSQASWFGSVFTLGAAAGGLSAMILNDLLGRKLSIMFSAVPSA
AGYALMAGAHGLWMLLLGRTLTGFAGGLTAACIPVYVSEIAPPGVRGALGATPQLMAVFG
SLSLYALGLLLPWRWLAVAGEAPVLIMILLLSFMPNSPRFLLSRGRDEEALRALAWLRGT
DVDVHWEFEQIQDNVRRQSSRVSWAEARAPHVCRPITVALLMRLLQQLTGITPILVYLQS
IFDSTAVLLPPKDDAAIVGAVRLLSVLIAALTMDLAGRKVLLFVSAAIMFAANLTLGLYI
HFGPRPLSPNSTAGLESESWGDLAQPLAAPAGYLTLVPLLATMLFIMGYAVGWGPITWLL
MSEVLPLRARGVASGLCVLASWLTAFVLTKSFLPVVSTFGLQVPFFFFAAICLVSLVFTG
CCVPETKGRSLEQIESFFRTGRRSFLR</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0013545|Solute carrier family 2, facilitated glucose transporter member 6 (SLC2A6)
ATGCAGGAGCCGCTGCTGGGAGCCGAGGGCCCGGACTACGACACCTTCCCCGAGAAGCCG
CCCCCGTCGCCAGGGGACAGGGCGCGGGTCGGGACCCTGCAGAACAAAAGGGTGTTCCTG
GCCACCTTCGCCGCAGTGCTCGGCAATTTCAGCTTTGGGTATGCCCTGGTCTACACATCC
CCTGTCATCCCAGCCCTGGAGCGCTCCTTGGATCCTGACCTGCATCTGACCAAATCCCAG
GCATCCTGGTTTGGGTCCGTGTTCACCCTGGGAGCAGCGGCCGGAGGCCTGAGTGCCATG
ATCCTCAACGACCTCCTGGGCCGGAAGCTGAGCATCATGTTCTCAGCTGTGCCGTCGGCG
GCCGGCTATGCGCTCATGGCGGGTGCGCACGGCCTCTGGATGCTGCTGCTCGGAAGGACG
CTGACGGGCTTCGCCGGGGGGCTCACAGCTGCCTGCATCCCGGTGTACGTGTCTGAGATT
GCTCCCCCAGGCGTTCGTGGGGCTCTGGGGGCCACACCCCAGCTCATGGCAGTGTTCGGA
TCCCTGTCCCTCTACGCCCTTGGCCTCCTGCTGCCGTGGCGCTGGCTGGCTGTGGCCGGG
GAGGCGCCTGTGCTCATCATGATCCTGCTGCTCAGCTTCATGCCCAACTCGCCGCGCTTC
CTGCTCTCTCGGGGCAGGGACGAAGAGGCCCTGCGGGCGCTGGCCTGGCTGCGTGGGACG
GACGTCGATGTCCACTGGGAGTTCGAGCAGATCCAGGACAACGTCCGGAGACAGAGCAGC
CGAGTATCGTGGGCTGAGGCACGGGCCCCACACGTGTGCCGGCCCATCACCGTGGCCTTG
CTGATGCGCCTCCTGCAGCAGCTGACGGGCATCACGCCCATCCTGGTCTACCTGCAGTCC
ATCTTCGACAGCACCGCTGTCCTGCTGCCCCCCAAGGACGACGCAGCCATCGTTGGGGCC
GTGCGGCTCCTGTCCGTGCTGATCGCCGCCCTCACCATGGACCTCGCAGGCCGCAAGGTG
CTGCTCTTCGTCTCAGGCTACGCCGTGGGCTGGGGTCCCATCACCTGGCTGCTCATGTCT
GAGGTCCTGCCCCTGCGTGCCCGTGGCGTGGCCTCAGGGCTCTGCGTGCTGGCCAGCTGG
CTCACCGCCTTCGTCCTCACCAAGTCCTTCCTGCCAGTGGTGAGCACCTTCGGCCTCCAG
GTGCCTTTCTTCTTCTTCGCGGCCATCTGCTTGGTGAGCCTGGTGTTCACAGGCTGCTGT
GTGCCCGAGACCAAGGGACGGTCCCTGGAGCAGATCGAGTCCTTCTTCCGCACGGGGAGA
AGGTCCTTCTTGCGCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00083</identifier>
        <name>Sugar_tr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glucose transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transmembrane transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="9">
      <id>BE0005218</id>
      <name>Solute carrier family 2, facilitated glucose transporter member 7</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles/>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="Q6PXP3" source="Swiss-Prot">
    <name>Solute carrier family 2, facilitated glucose transporter member 7</name>
    <general-function>Substrate-specific transmembrane transporter activity</general-function>
    <specific-function>High-affinity transporter for glucose and fructose Does not transport galactose, 2-deoxy-d-glucose and xylose.</specific-function>
    <gene-name>SLC2A7</gene-name>
    <locus/>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>22-42
79-99
108-128
139-159
173-193
199-219
282-302
322-342
351-371
380-400
416-436
446-466</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi/>
    <molecular-weight>55726.915</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:13445</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q6PXP3</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GTR7_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Glucose transporter type 7</synonym>
      <synonym>GLUT-7</synonym>
      <synonym>GLUT7</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0019707|Solute carrier family 2, facilitated glucose transporter member 7
MENKEAGTPPPIPSREGRLQPTLLLATLSAAFGSAFQYGYNLSVVNTPHKVFKSFYNETY
FERHATFMDGKLMLLLWSCTVSMFPLGGLLGSLLVGLLVDSCGRKGTLLINNIFAIIPAI
LMGVSKVAKAFELIVFSRVVLGVCAGISYSALPMYLGELAPKNLRGMVGTMTEVFVIVGV
FLAQIFSLQAILGNPAGWPVLLALTGVPALLQLLTLPFFPESPRYSLIQKGDEATARQAL
RRLRGHTDMEAELEDMRAEARAERAEGHLSVLHLCALRSLRWQLLSIIVLMAGQQLSGIN
AINYYADTIYTSAGVEAAHSQYVTVGSGVVNIVMTITSAVLVERLGRRHLLLAGYGICGS
ACLVLTVVLLFQNRVPELSYLGIICVFAYIAGHSIGPSPVPSVVRTEIFLQSSRRAAFMV
DGAVHWLTNFIIGFLFPSIQEAIGAYSFIIFAGICLLTAIYIYVVIPETKGKTFVEINRI
FAKRNRVKLPEEKEETIDAGPPTASPAKETSF</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019708|Solute carrier family 2, facilitated glucose transporter member 7 (SLC2A7)
ATGGAGAACAAAGAGGCGGGAACCCCTCCACCCATTCCATCCAGGGAGGGGCGGCTCCAG
CCGACGCTGTTGCTGGCGACACTGAGCGCGGCCTTTGGCTCAGCCTTCCAGTACGGCTAC
AACCTCTCTGTGGTCAACACGCCGCACAAGGTCTTCAAGTCATTTTACAACGAAACCTAC
TTTGAGCGACACGCAACATTCATGGACGGGAAGCTCATGCTGCTTCTATGGTCTTGCACC
GTCTCCATGTTTCCTCTGGGCGGCCTGTTGGGGTCATTGCTCGTGGGCCTGCTGGTTGAT
AGCTGCGGCAGAAAGGGGACCCTGCTGATCAACAACATCTTTGCCATCATCCCCGCCATC
CTGATGGGAGTCAGCAAAGTGGCCAAGGCTTTTGAGCTGATCGTCTTTTCCCGAGTGGTG
CTGGGAGTCTGTGCAGGCATCTCCTACAGCGCCCTTCCCATGTACCTGGGAGAACTGGCC
CCCAAGAACCTGAGAGGCATGGTGGGAACAATGACCGAGGTTTTCGTCATCGTTGGAGTC
TTCCTAGCACAGATCTTCAGCCTCCAGGCCATCTTGGGCAACCCGGCAGGCTGGCCGGTG
CTTCTGGCGCTCACAGGGGTGCCCGCCCTGCTGCAGCTGCTGACCCTGCCCTTCTTCCCC
GAAAGCCCCCGCTACTCCCTGATTCAGAAAGGAGATGAAGCCACAGCGCGACAAGCTCTG
AGGAGGCTGAGAGGCCACACGGACATGGAGGCCGAGCTGGAGGACATGCGTGCGGAGGCC
CGGGCCGAGCGCGCCGAGGGCCACCTGTCTGTGCTGCACCTCTGTGCCCTGCGGTCCCTG
CGCTGGCAGCTCCTCTCCATCATCGTGCTCATGGCCGGCCAGCAGCTGTCGGGCATCAAT
GCGATCAACTACTATGCGGACACCATCTACACATCTGCGGGCGTGGAGGCCGCTCACTCC
CAATATGTAACGGTGGGCTCTGGCGTCGTCAACATAGTGATGACCATCACCTCGGCTGTC
CTTGTGGAGCGGCTGGGACGGCGGCACCTCCTGCTGGCCGGCTACGGCATCTGCGGCTCT
GCCTGCCTGGTGCTGACGGTGGTGCTCCTATTCCAGAACAGGGTCCCCGAGCTGTCCTAC
CTCGGCATCATCTGTGTCTTTGCCTACATCGCGGGACATTCCATTGGGCCCAGTCCTGTC
CCCTCGGTGGTGAGGACCGAGATCTTCCTGCAGTCCTCCCGGCGGGCAGCTTTCATGGTG
GACGGGGCAGTGCACTGGCTCACCAACTTCATCATAGGCTTCCTGTTCCCATCCATCCAG
GAGGCCATCGGTGCCTACAGTTTCATCATCTTTGCCGGAATCTGCCTCCTCACTGCGATT
TACATCTACGTGGTTATTCCGGAGACCAAGGGCAAAACATTTGTGGAGATAAACCGCATT
TTTGCCAAGAGAAACAGGGTGAAGCTTCCAGAGGAGAAAGAAGAAACCATTGATGCTGGG
CCTCCCACAGCCTCTCCTGCCAAGGAAACTTCCTTTTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00083</identifier>
        <name>Sugar_tr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>substrate-specific transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="10">
      <id>BE0005219</id>
      <name>Solute carrier family 2, facilitated glucose transporter member 8</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles/>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="Q9NY64" source="Swiss-Prot">
    <name>Solute carrier family 2, facilitated glucose transporter member 8</name>
    <general-function>Glucose transmembrane transporter activity</general-function>
    <specific-function>Insulin-regulated facilitative glucose transporter. Binds cytochalasin B in a glucose-inhibitable manner. Seems to be a dual-specific sugar transporter as it is inhibitable by fructose (By similarity).</specific-function>
    <gene-name>SLC2A8</gene-name>
    <locus/>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>26-46
71-91
97-117
128-148
157-177
183-203
257-277
293-313
320-340
368-388
405-425
439-459</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi/>
    <molecular-weight>50818.54</molecular-weight>
    <chromosome-location>9</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:13812</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9NY64</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GTR8_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Glucose transporter type 8</synonym>
      <synonym>Glucose transporter type X1</synonym>
      <synonym>GLUT-8</synonym>
      <synonym>GLUT8</synonym>
      <synonym>GLUTX1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0013546|Solute carrier family 2, facilitated glucose transporter member 8
MTPEDPEETQPLLGPPGGSAPRGRRVFLAAFAAALGPLSFGFALGYSSPAIPSLQRAAPP
APRLDDAAASWFGAVVTLGAAAGGVLGGWLVDRAGRKLSLLLCSVPFVAGFAVITAAQDV
WMLLGGRLLTGLACGVASLVAPVYISEIAYPAVRGLLGSCVQLMVVVGILLAYLAGWVLE
WRWLAVLGCVPPSLMLLLMCFMPETPRFLLTQHRRQEAMAALRFLWGSEQGWEDPPIGAE
QSFHLALLRQPGIYKPFIIGVSLMAFQQLSGVNAVMFYAETIFEEAKFKDSSLASVVVGV
IQVLFTAVAALIMDRAGRRLLLVLSGVVMVFSTSAFGAYFKLTQGGPGNSSHVAISAPVS
AQPVDASVGLAWLAVGSMCLFIAGFAVGWGPIPWLLMSEIFPLHVKGVATGICVLTNWLM
AFLVTKEFSSLMEVLRPYGAFWLASAFCIFSVLFTLFCVPETKGKTLEQITAHFEGR</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0013547|Solute carrier family 2, facilitated glucose transporter member 8 (SLC2A8)
ATGACGCCCGAGGACCCAGAGGAAACCCAGCCGCTTCTGGGGCCTCCTGGCGGCAGCGCG
CCCCGCGGCCGCCGCGTCTTCCTCGCCGCCTTCGCCGCTGCCCTGGGCCCACTCAGCTTC
GGCTTCGCGCTCGGCTACAGCTCCCCGGCCATCCCTAGCCTGCAGCGCGCCGCGCCCCCG
GCCCCGCGCCTGGACGACGCCGCCGCCTCCTGGTTCGGGGCTGTCGTGACCCTGGGTGCC
GCGGCGGGGGGAGTGCTGGGCGGCTGGCTGGTGGACCGCGCCGGGCGCAAGCTGAGCCTC
TTGCTGTGCTCCGTGCCCTTCGTGGCCGGCTTTGCCGTCATCACCGCGGCCCAGGACGTG
TGGATGCTGCTGGGGGGCCGCCTCCTCACCGGCCTGGCCTGCGGTGTTGCCTCCCTAGTG
GCCCCGGTCTACATCTCCGAAATCGCCTACCCAGCAGTCCGGGGGTTGCTCGGCTCCTGT
GTGCAGCTAATGGTCGTCGTCGGCATCCTCCTGGCCTACCTGGCAGGCTGGGTGCTGGAG
TGGCGCTGGCTGGCTGTGCTGGGCTGCGTGCCCCCCTCCCTCATGCTGCTTCTCATGTGC
TTCATGCCCGAGACCCCGCGCTTCCTGCTGACTCAGCACAGGCGCCAGGAGGCCATGGCC
GCCCTGCGGTTCCTGTGGGGCTCCGAGCAGGGCTGGGAAGACCCCCCCATCGGGGCTGAG
CAGAGCTTTCACCTGGCCCTGCTGCGGCAGCCCGGCATCTACAAGCCCTTCATCATCGGC
GTCTCCCTGATGGCCTTCCAGCAGCTGTCGGGGGTCAACGCCGTCATGTTCTATGCAGAG
ACCATCTTTGAAGAGGCCAAGTTCAAGGACAGCAGCCTGGCCTCGGTCGTCGTGGGTGTC
ATCCAGGTGCTGTTCACAGCTGTGGCGGCTCTCATCATGGACAGAGCAGGGCGGAGGCTG
CTCCTGGTCTTGTCAGGTGTGGTCATGGTGTTCAGCACGAGTGCCTTCGGCGCCTACTTC
AAGCTGACCCAGGGTGGCCCTGGCAACTCCTCGCACGTGGCCATCTCGGCGCCTGTCTCT
GCACAGCCTGTTGATGCCAGCGTGGGGCTGGCCTGGCTGGCCGTGGGCAGCATGTGCCTC
TTCATCGCCGGAGGTCCTCAGGCCCTATGGAGCCTTCTGGCTTGCCTCCGCTTTCTGCAT
CTTCAGTGTCCTTTTCACTTTGTTCTGTGTCCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00083</identifier>
        <name>Sugar_tr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>lysosomal membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasmic vesicle membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>synaptic vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glucose binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glucose transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>insulin receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to hypoxia</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>male meiosis I</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="11">
      <id>BE0005220</id>
      <name>Solute carrier family 2, facilitated glucose transporter member 10</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles/>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="O95528" source="Swiss-Prot">
    <name>Solute carrier family 2, facilitated glucose transporter member 10</name>
    <general-function>Sugar:proton symporter activity</general-function>
    <specific-function>Facilitative glucose transporter.</specific-function>
    <gene-name>SLC2A10</gene-name>
    <locus/>
    <cellular-location>Endomembrane system</cellular-location>
    <transmembrane-regions>16-36
49-69
78-98
107-127
135-155
167-187
234-254
270-290
299-319
415-435
446-466
477-497</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi/>
    <molecular-weight>56910.77</molecular-weight>
    <chromosome-location>20</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:13444</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O95528</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GTR10_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Glucose transporter type 10</synonym>
      <synonym>GLUT-10</synonym>
      <synonym>GLUT10</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0017660|Solute carrier family 2, facilitated glucose transporter member 10
MGHSPPVLPLCASVSLLGGLTFGYELAVISGALLPLQLDFGLSCLEQEFLVGSLLLGALL
ASLVGGFLIDCYGRKQAILGSNLVLLAGSLTLGLAGSLAWLVLGRAVVGFAISLSSMACC
IYVSELVGPRQRGVLVSLYEAGITVGILLSYALNYALAGTPWGWRHMFGWATAPAVLQSL
SLLFLPAGTDETATHKDLIPLQGGEAPKLGPGRPRYSFLDLFRARDNMRGRTTVGLGLVL
FQQLTGQPNVLCYASTIFSSVGFHGGSSAVLASVGLGAVKVAATLTAMGLVDRAGRRALL
LAGCALMALSVSGIGLVSFAVPMDSGPSCLAVPNATGQTGLPGDSGLLQDSSLPPIPRTN
EDQREPILSTAKKTKPHPRSGDPSAPPRLALSSALPGPPLPARGHALLRWTALLCLMVFV
SAFSFGFGPVTWLVLSEIYPVEIRGRAFAFCNSFNWAANLFISLSFLDLIGTIGLSWTFL
LYGLTAVLGLGFIYLFVPETKGQSLAEIDQQFQKRRFTLSFGHRQNSTGIPYSRIEISAA
S</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0017661|Solute carrier family 2, facilitated glucose transporter member 10 (SLC2A10)
ATGGGCCACTCCCCACCTGTCCTGCCTTTGTGTGCCTCTGTGTCTTTGCTGGGTGGCCTG
ACCTTTGGTTATGAACTGGCAGTCATATCAGGTGCCCTGCTGCCACTGCAGCTTGACTTT
GGGCTAAGCTGCTTGGAGCAGGAGTTCCTGGTGGGCAGCCTGCTCCTGGGGGCTCTCCTC
GCCTCCCTGGTTGGTGGCTTCCTCATTGACTGCTATGGCAGGAAGCAAGCCATCCTCGGG
AGCAACTTGGTGCTGCTGGCAGGCAGCCTGACCCTGGGCCTGGCTGGTTCCCTGGCCTGG
CTGGTCCTGGGCCGCGCTGTGGTTGGCTTCGCCATTTCCCTCTCCTCCATGGCTTGCTGT
ATCTACGTGTCAGAGCTGGTGGGGCCACGGCAGCGGGGAGTGCTGGTGTCCCTCTATGAG
GCAGGCATCACCGTGGGCATCCTGCTCTCCTATGCCCTCAACTATGCACTGGCTGGTACC
CCCTGGGGATGGAGGCACATGTTCGGCTGGGCCACTGCACCTGCTGTCCTGCAATCCCTC
AGCCTCCTCTTCCTCCCTGCTGGTACAGATGAGACTGCAACACACAAGGACCTCATCCCA
CTCCAGGGAGGTGAGGCCCCCAAGCTGGGCCCGGGGAGGCCACGGTACTCCTTTCTGGAC
CTCTTCAGGGCACGCGATAACATGCGAGGCCGGACCACAGTGGGCCTGGGGCTGGTGCTC
TTCCAGCAACTAACAGGGCAGCCCAACGTGCTGTGCTATGCCTCCACCATCTTCAGCTCC
GTTGGTTTCCATGGGGGATCCTCAGCCGTGCTGGCCTCTGTGGGGCTTGGCGCAGTGAAG
GTGGCAGCTACCCTGACCGCCATGGGGCTGGTGGACCGTGCAGGCCGCAGGGCTCTGTTG
CTAGCTGGCTGTGCCCTCATGGCCCTGTCCGTCAGTGGCATAGGCCTCGTCAGCTTTGCC
GTGCCCATGGACTCAGGCCCAAGCTGTCTGGCTGTGCCCAATGCCACCGGGCAGACAGGC
CTCCCTGGAGACTCTGGCCTGCTGCAGGACTCCTCTCTACCTCCCATTCCAAGGACCAAT
GAGGACCAAAGGGAGCCAATCTTGTCCACTGCTAAGAAAACCAAGCCCCATCCCAGATCT
GGAGACCCCTCAGCCCCTCCTCGGCTGGCCCTGAGCTCTGCCCTCCCTGGGCCCCCTCTG
CCCGCTCGGGGGCATGCACTGCTGCGCTGGACCGCACTGCTGTGCCTGATGGTCTTTGTC
AGTGCCTTCTCCTTTGGGTTTGGGCCAGTGACCTGGCTTGTCCTCAGCGAGATCTACCCT
GTGGAGATACGAGGAAGAGCCTTCGCCTTCTGCAACAGCTTCAACTGGGCGGCCAACCTC
TTCATCAGCCTCTCCTTCCTCGATCTCATTGGCACCATCGGCTTGTCCTGGACCTTCCTG
CTCTACGGACTGACCGCTGTCCTCGGCCTGGGCTTCATCTATTTATTTGTTCCTGAAACA
AAAGGCCAGTCGTTGGCAGAGATAGACCAGCAGTTCCAGAAGAGACGGTTCACCCTGAGC
TTTGGCCACAGGCAGAACTCCACTGGCATCCCGTACAGCCGCATCGAGATCTCTGCGGCC
TCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00083</identifier>
        <name>Sugar_tr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>endomembrane system</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>perinuclear region of cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sugar</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>proton transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="12">
      <id>BE0005221</id>
      <name>Solute carrier family 2, facilitated glucose transporter member 11</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles/>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="Q9BYW1" source="Swiss-Prot">
    <name>Solute carrier family 2, facilitated glucose transporter member 11</name>
    <general-function>Substrate-specific transmembrane transporter activity</general-function>
    <specific-function>Facilitative glucose transporter.</specific-function>
    <gene-name>SLC2A11</gene-name>
    <locus/>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>12-32
62-82
98-118
129-149
158-178
188-208
274-294
312-332
339-359
365-385
409-429
436-456</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi/>
    <molecular-weight>53702.055</molecular-weight>
    <chromosome-location>22</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:14239</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9BYW1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GTR11_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Glucose transporter type 10</synonym>
      <synonym>Glucose transporter type 11</synonym>
      <synonym>GLUT-10</synonym>
      <synonym>GLUT-11</synonym>
      <synonym>GLUT10</synonym>
      <synonym>GLUT11</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0008985|Solute carrier family 2, facilitated glucose transporter member 11
MRALRRLIQGRILLLTICAAGIGGTFQFGYNLSIINAPTLHIQEFTNETWQARTGEPLPD
HLVLLMWSLIVSLYPLGGLFGALLAGPLAITLGRKKSLLVNNIFVVSAAILFGFSRKAGS
FEMIMLGRLLVGVNAGVSMNIQPMYLGESAPKELRGAVAMSSAIFTALGIVMGQVVGLRE
LLGGPQAWPLLLASCLVPGALQLASLPLLPESPRYLLIDCGDTEACLAALRRLRGSGDLA
GELEELEEERAACQGCRARRPWELFQHRALRRQVTSLVVLGSAMELCGNDSVYAYASSVF
RKAGVPEAKIQYAIIGTGSCELLTAVVSCVVIERVGRRVLLIGGYSLMTCWGSIFTVALC
LQSSFPWTLYLAMACIFAFILSFGIGPAGVTGILATELFDQMARPAACMVCGALMWIMLI
LVGLGFPFIMEALSHFLYVPFLGVCVCGAIYTGLFLPETKGKTFQEISKELHRLNFPRRA
QGPTWRSLEVIQSTEL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0013548|Solute carrier family 2, facilitated glucose transporter member 11 (SLC2A11)
ATGAGAGCGCTCCGAAGACTGATTCAGGGCAGGATCCTGCTCCTGACCATCTGCGCTGCC
GGCATTGGTGGGACTTTTCAGTTTGGCTATAACCTCTCTATCATCAATGCCCCGACCTTG
CACATTCAGGAATTCACCAATGAGACATGGCAGGCGCGTACTGGAGAGCCACTGCCCGAT
CACCTAGTCCTGCTTATGTGGTCCCTCATCGTGTCTCTGTATCCCCTGGGAGGCCTCTTT
GGAGCACTGCTTGCAGGTCCCTTGGCCATCACGCTGGGAAGGAAGAAGTCCCTCCTGGTG
AATAACATCTTTGTGGTGTCAGCAGCAATCCTGTTTGGATTCAGCCGCAAAGCAGGCTCC
TTTGAGATGATCATGCTGGGAAGACTGCTCGTGGGAGTCAATGCAGGTGTGAGCATGAAC
ATCCAGCCCATGTACCTGGGGGAGAGCGCCCCTAAGGAGCTCCGAGGAGCTGTGGCCATG
AGCTCAGCCATCTTTACGGCTCTGGGGATCGTGATGGGACAGGTGGTCGGACTCAGGGAG
CTCCTAGGTGGCCCTCAGGCCTGGCCCCTGCTGCTGGCCAGCTGCCTGGTGCCCGGGGCG
CTCCAGCTCGCCTCCCTGCCTCTGCTCCCTGAAAGCCCGCGCTACCTCCTCATTGACTGT
GGAGACACCGAGGCCTGCCTGGCAGCACTACGGCGGCTCCGGGGCTCCGGGGACTTGGCA
GGGGAGCTGGAGGAGCTGGAGGAGGAGCGCGCTGCCTGCCAGGGCTGCCGTGCCCGGCGC
CCATGGGAGCTGTTCCAGCATCGGGCCCTGAGGAGACAGGTGACAAGCCTCGTGGTTCTG
GGCAGTGCCATGGAGCTCTGCGGGAATGACTCGGTGTACGCCTACGCCTCCTCCGTGTTC
CGGAAGGCAGGAGTGCCGGAAGCGAAGATCCAGTACGCGATCATCGGGACTGGGAGCTGC
GAGCTGCTCACGGCGGTTGTTAGTTGTGTGGTAATCGAGAGGGTGGGTCGGCGCGTGCTG
CTCATCGGTGGGTACAGCCTGATGACCTGCTGGGGGAGCATCTTCACTGTGGCCCTGTGC
CTGCAGAGCTCCTTCCCCTGGACACTCTACCTGGCCATGGCCTGCATCTTTGCCTTCATC
CTCAGCTTTGGCATTGGCCCTGCCGGAGTGACGGGGATCCTGGCCACAGAGCTGTTTGAC
CAGATGGCCAGGCCTGCTGCCTGCATGGTCTGCGGGGCGCTCATGTGGATCATGCTCATC
CTGGTCGGCCTGGGATTTCCCTTTATCATGGAGGCCTTGTCCCACTTCCTCTATGTCCCT
TTCCTTGGTGTCTGTGTCTGTGGGGCCATCTACACTGGCCTGTTCCTTCCTGAGACCAAA
GGCAAGACCTTCCAAGAGATCTCCAAGGAATTACACAGACTCAACTTCCCCAGGCGGGCC
CAGGGCCCCACGTGGAGGAGCCTGGAGGTTATCCAGTCAACAGAACTCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00083</identifier>
        <name>Sugar_tr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>substrate-specific transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="13">
      <id>BE0005222</id>
      <name>Solute carrier family 2, facilitated glucose transporter member 12</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles/>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="Q8TD20" source="Swiss-Prot">
    <name>Solute carrier family 2, facilitated glucose transporter member 12</name>
    <general-function>Substrate-specific transmembrane transporter activity</general-function>
    <specific-function>Facilitative glucose transporter.</specific-function>
    <gene-name>SLC2A12</gene-name>
    <locus/>
    <cellular-location>Endomembrane system</cellular-location>
    <transmembrane-regions>45-65
81-101
116-136
138-158
173-193
198-218
279-299
318-338
346-366
467-487
499-519
529-549</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi/>
    <molecular-weight>66965.7</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:18067</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q8TD20</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GTR12_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Glucose transporter type 12</synonym>
      <synonym>GLUT-12</synonym>
      <synonym>GLUT12</synonym>
      <synonym>GLUT8</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0008986|Solute carrier family 2, facilitated glucose transporter member 12
MVPVENTEGPSLLNQKGTAVETEGSGSRHPPWARGCGMFTFLSSVTAAVSGLLVGYELGI
ISGALLQIKTLLALSCHEQEMVVSSLVIGALLASLTGGVLIDRYGRRTAIILSSCLLGLG
SLVLILSLSYTVLIVGRIAIGVSISLSSIATCVYIAEIAPQHRRGLLVSLNELMIVIGIL
SAYISNYAFANVFHGWKYMFGLVIPLGVLQAIAMYFLPPSPRFLVMKGQEGAASKVLGRL
RALSDTTEELTVIKSSLKDEYQYSFWDLFRSKDNMRTRIMIGLTLVFFVQITGQPNILFY
ASTVLKSVGFQSNEAASLASTGVGVVKVISTIPATLLVDHVGSKTFLCIGSSVMAASLVT
MGIVNLNIHMNFTHICRSHNSINQSLDESVIYGPGNLSTNNNTLRDHFKGISSHSRSSLM
PLRNDVDKRGETTSASLLNAGLSHTEYQIVTDPGDVPAFLKWLSLASLLVYVAAFSIGLG
PMPWLVLSEIFPGGIRGRAMALTSSMNWGINLLISLTFLTVTDLIGLPWVCFIYTIMSLA
SLLFVVMFIPETKGCSLEQISMELAKVNYVKNNICFMSHHQEELVPKQPQKRKPQEQLLE
CNKLCGRGQSRQLSPET</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020846|Solute carrier family 2, facilitated glucose transporter member 12 (SLC2A12)
ATGGTACCTGTTGAAAACACCGAGGGCCCCAGTCTGCTGAACCAGAAGGGGACAGCCGTG
GAGACGGAGGGCAGCGGCAGCCGGCATCCTCCCTGGGCGAGAGGCTGCGGCATGTTTACC
TTCCTGTCATCTGTCACTGCTGCTGTCAGTGGCCTCCTGGTGGGTTATGAACTTGGGATC
ATCTCTGGGGCTCTTCTTCAGATCAAAACCTTATTAGCCCTGAGCTGCCATGAGCAGGAA
ATGGTTGTGAGCTCCCTCGTCATTGGAGCCCTCCTTGCCTCACTCACCGGAGGGGTCCTG
ATAGACAGATATGGAAGAAGGACAGCAATCATCTTGTCATCCTGCCTGCTTGGACTCGGA
AGCTTAGTCTTGATCCTCAGTTTATCCTACACGGTTCTTATAGTGGGACGCATTGCCATA
GGGGTCTCCATCTCCCTCTCTTCCATTGCCACTTGTGTTTACATCGCAGAGATTGCTCCT
CAACACAGAAGAGGCCTTCTTGTGTCACTGAATGAGCTGATGATTGTCATCGGCATTCTT
TCTGCCTATATTTCAAATTACGCATTTGCCAATGTTTTCCATGGCTGGAAGTACATGTTT
GGTCTTGTGATTCCCTTGGGAGTTTTGCAAGCAATTGCAATGTATTTTCTTCCTCCAAGC
CCTCGGTTTCTGGTGATGAAAGGACAAGAGGGAGCTGCTAGCAAGGTTCTTGGAAGGTTA
AGAGCACTCTCAGATACAACTGAGGAACTCACTGTGATCAAATCCTCCCTGAAAGATGAA
TATCAGTACAGTTTTTGGGATCTGTTTCGTTCAAAAGACAACATGCGGACCCGAATAATG
ATAGGACTAACACTAGTATTTTTTGTACAAATCACTGGCCAACCAAACATATTGTTCTAT
GCATCAACTGTTTTGAAGTCAGTTGGATTTCAAAGCAATGAGGCAGCTAGCCTCGCCTCC
ACTGGGGTTGGAGTCGTCAAGGTCATTAGCACCATCCCTGCCACTCTTCTTGTAGACCAT
GTCGGCAGCAAAACATTCCTCTGCATTGGCTCCTCTGTGATGGCAGCTTCGTTGGTGACC
ATGGGCATCGTAAATCTCAACATCCACATGAACTTCACCCATATCTGCAGAAGCCACAAT
TCTATCAACCAGTCCTTGGATGAGTCTGTGATTTATGGACCAGGAAACCTGTCAACCAAC
AACAATACTCTCAGAGACCACTTCAAAGGGATTTCTTCCCATAGCAGAAGCTCACTCATG
CCCCTGAGAAATGATGTGGATAAGAGAGGGGAGACGACCTCAGCATCCTTGCTAAATGCT
GGATTAAGCCACACTGAATACCAGATAGTCACAGACCCTGGGGACGTCCCAGCTTTTTTG
AAATGGCTGTCCTTAGCCAGCTTGCTTGTTTATGTTGCTGCTTTTTCAATTGGTCTAGGA
CCAATGCCCTGGCTGGTGCTCAGCGAGATCTTTCCTGGTGGGATCAGAGGACGAGCCATG
GCTTTAACTTCTAGCATGAACTGGGGCATCAATCTCCTCATCTCGCTGACATTTTTGACT
GTAACTGATCTTATTGGCCTGCCATGGGTGTGCTTTATATATACAATCATGAGTCTAGCA
TCCCTGCTTTTTGTTGTTATGTTTATACCTGAGACAAAGGGATGCTCTTTGGAACAAATA
TCAATGGAGCTAGCAAAAGTGAACTATGTGAAAAACAACATTTGTTTTATGAGTCATCAC
CAAGAAGAATTAGTGCCAAAACAGCCTCAAAAAAGAAAACCCCAGGAGCAGCTCTTGGAG
TGTAACAAGCTGTGTGGTAGGGGCCAATCCAGGCAGCTTTCTCCAGAGACCTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00083</identifier>
        <name>Sugar_tr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>endomembrane system</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>perinuclear region of cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>substrate-specific transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
  </transporters>
</drug>
